These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 18875384)

  • 1. Studies on lymphogranuloma venereum complement-fixing antigens; fractionation with organic solvents of antigens of the psittacosis-lymphogranuloma venereum group.
    HILLEMAN MR; NIGG C
    J Immunol; 1948 Aug; 59(4):349-64. PubMed ID: 18875384
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on lymphogranuloma venereum complement-fixing antigens; fractionation with organic solvents of antigens of the psittacosis lymphogranuloma venereum group.
    HILLEMAN MR; NIGG C
    J Bacteriol; 1947 Jul; 54(1):59. PubMed ID: 20344286
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic studies on the psittacosis-lymphogranuloma venereum group of viruses. II. Characterization of complement-fixing antigens extracted with sodium lauryl sulfate.
    BENEDICT AA; O'BRIEN E
    J Immunol; 1956 Apr; 76(4):293-300. PubMed ID: 13319707
    [No Abstract]   [Full Text] [Related]  

  • 4. PREPARATION OF A STABLE PSITTACOSIS-LYMPHOGRANULOMA VENEREUM GROUP COMPLEMENT FIXING ANTIGEN.
    MARABLE IW; NADEL MK
    Am J Med Technol; 1964; 30():94-8. PubMed ID: 14128185
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the stability of substances in human sera which are inhibitory in complement-fixing antigen-antibody systems of lymphogranuloma venereum and psittacosis.
    SCHMIDT NJ; HARDING HB
    Q Bull Northwest Univ Med Sch; 1955; 29(3):241-3. PubMed ID: 13273593
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of complement fixation by certain serums when tested against psittacosis and lymphogranuloma venereum antigens.
    SCHMIDT N; HARDING HB; HEPLER OE; MURMANN E
    J Infect Dis; 1952; 91(2):173-9. PubMed ID: 12981276
    [No Abstract]   [Full Text] [Related]  

  • 7. TYPE-SPECIFIC ANTIGENS IN THE PSITTACOSIS-LYMPHOGRANULOMA VENEREUM GROUP OF ORGANISMS.
    FRASER CE; BERMAN DT
    J Bacteriol; 1965 Apr; 89(4):943-8. PubMed ID: 14276119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group-specificity of psittacosis-lymphogranuloma venereum group skin test antigens in lymphogranuloma venereum patients.
    HILLEMAN MR; GREAVES AB; WERNER JH
    J Lab Clin Med; 1958 Jul; 52(1):53-7. PubMed ID: 13549848
    [No Abstract]   [Full Text] [Related]  

  • 9. The Use of Complement-Fixation Tests in the Study and Diagnosis of Viral Diseases in Man and Animals - A Review: Part VII. The Psittacosis-Lymphogranuloma Venereum Group.
    Rice CE
    Can J Comp Med Vet Sci; 1961 Mar; 25(3):74-9. PubMed ID: 17649291
    [No Abstract]   [Full Text] [Related]  

  • 10. The antigenic relationship of lymphogranuloma venereum and psittacosis by skin test in humans.
    POLLARD M; WITKA TM
    Tex Rep Biol Med; 1947; 5(3):288-93. PubMed ID: 20269730
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on lymphogranuloma venereum complement-fixing antigens; serological studies with boiled phenolized antigens.
    BOWSER BM; NIGG C
    J Immunol; 1946 Jul; 53(3):269-75. PubMed ID: 20992663
    [No Abstract]   [Full Text] [Related]  

  • 12. The indirect complement fixation hemagglutination and conglutinating complement absorption tests for viruses of the psittacosis-lymphogranuloma venereum group.
    HILLEMAN MR; HAIG DA; HELMOLD RJ
    J Immunol; 1951 Jan; 66(1):115-30. PubMed ID: 14814295
    [No Abstract]   [Full Text] [Related]  

  • 13. The enhancement and properties of the complement-fixing antigens of lymphogranuloma venereum.
    NIGG C; HILLEMAN MR; BOWSER BM
    Fed Proc; 1946; 5(1 Pt 2):251. PubMed ID: 20984592
    [No Abstract]   [Full Text] [Related]  

  • 14. The toxins of the psittacosis-lymphogranuloma group of agents; the toxicity of various members of the psittacosis-lymphogranuloma venereum group.
    MANIRE GP; MEYER KF
    J Infect Dis; 1950; 86(3):226-32. PubMed ID: 15415625
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on lymphogranuloma venereum complement-fixing antigens the solubility in ether of an active fraction.
    HILLEMAN MR; NIGG C
    J Immunol; 1946 Jun; 53():201-8. PubMed ID: 20988501
    [No Abstract]   [Full Text] [Related]  

  • 16. The stability of human complement-fixing antibodies against lymphogranuloma venereum, psittacosis, influenza A, and influenza B antigens under various conditions of storage.
    SCHMIDT N; HARDING HB; HEPLER OE
    J Lab Clin Med; 1954 Apr; 43(4):637-46. PubMed ID: 13163563
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the chemotherapy of viruses in the psittacosis-lymphogranuloma venereum group; effect of certain chemotherapeutic agents on the growth of psittacosis virus (6BC strain) in tissues cultures and eggs.
    EARLY RL; MORGAN HR
    J Immunol; 1946 Jun; 53():151-6. PubMed ID: 20988495
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement-fixing antibodies of lymphogranuloma venereum in mice; their development and response to sulfonamide therapy.
    WALL MJ
    J Immunol; 1947 Apr; 55(4):353-61. PubMed ID: 20294489
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on lymphogranuloma venereum complement-fixing antigens; enhancement by phenol or boiling.
    NIGG C; HILLEMAN MR; BOWSER BM
    J Immunol; 1946 Jul; 53(3):259-68. PubMed ID: 20992662
    [No Abstract]   [Full Text] [Related]  

  • 20. Some observations on the antigenic structure of psittacosis and lymphogranuloma venereum viruses. I. Preparation and use in complement fixation tests of antisera from different sources.
    BARWELL CF
    Br J Exp Pathol; 1952 Jun; 33(3):258-67. PubMed ID: 14935091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.